Chinese State Media Refutes Trump on Tariffs, Fentanyl
(Bloomberg) -- The latest tariff move by the U.S. has “seriously breached” the truce that Presidents Donald Trump and Xi Jinping agreed in Japan in late June and isn't doing any good to trade talks, according to a People's Daily commentary.
“It deviates from the correct track and is not conducive to solving the problem,” the paper, mouthpiece of the Communist Party said on Saturday. “The Chinese side is strongly dissatisfied and resolutely opposed.”
Trump announced Thursday that he would impose a 10% tariff on a further $300 billion in Chinese imports, a move set to hit American consumers more directly than his other tariffs so far. The new duties will be imposed beginning Sept. 1 on a long list of goods expected to include smart-phones, laptop computers and children's clothing.
“The U.S.'s escalation of trade frictions and tariffs are inconsistent with the interests of the Chinese and American people and the interests of the world and will have a declining impact on the world economy,” according to the commentary. “China is committed to international cooperation, but is not afraid of any extreme pressure.”
In a tweet, Trump said China hadn't lived up to a promise Xi made in Osaka to buy U.S. agricultural goods and to halt illegal exports of fentanyl.
Chinese companies are making inquiries to buy more American farm products, the paper said. The country is willing to strengthen its cooperation with the U.S. on drug control, and is cracking down on illegal production and smuggling of fentanyl, it said.
The U.S. needs to examine why it has an opioid crisis instead of blaming China, according to the commentary.
“China has adopted stricter controls than the U.S.,” Liu Yuejin, deputy head of China National Narcotics Control Commission, said in an interview on state television CCTV. China has strict controls over 25 types of fentanyl-related substances, which is more than what's listed by the United Nations, he said.
“The root cause of the fentanyl issue in the U.S. does not lie with China,” China's foreign ministry spokeswoman Hua Chunying was quoted as saying by the official Xinhua News Agency.
--With assistance from Niu Shuping.
To contact Bloomberg News staff for this story: Gao Yuan in Beijing at ygao199@bloomberg.net
To contact the editors responsible for this story: Shamim Adam at sadam2@bloomberg.net, Marcus Wright
©2019 Bloomberg L.P.
With assistance from Bloomberg
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.